Blockade of hepatic alpha-adrenergic receptors and responses by chlorpromazine and trifluoperazine.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000818:Animals; D000001:Calcimycin / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D002147:Calmodulin / Q000502:physiology; D002746:Chlorpromazine / Q000494:pharmacology*; D004789:Enzyme Activation / Q000187:drug effects; D008099:Liver / Q000378:metabolism*; D010656:Phenylephrine / Q000494:pharmacology; D006005:Phosphorylases / Q000378:metabolism; D013552:Swine; D014268:Trifluoperazine / Q000494:pharmacology*; D014667:Vasopressins / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D002147:Calmodulin; D014667:Vasopressins; D010656:Phenylephrine; D014268:Trifluoperazine; D000001:Calcimycin; D006005:Phosphorylases; D002118:Calcium; D002746:Chlorpromazine